These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2659294)

  • 1. Aztreonam in the treatment of urinary tract infections: a multicenter trial.
    Martelli A; Cortecchia V; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():8-14. PubMed ID: 2659294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter comparative trial of aztreonam in the treatment of gram-negative infections in compromised intensive-care patients.
    Rabinad E; Bosch-Perez A
    Chemotherapy; 1989; 35 Suppl 1():1-7. PubMed ID: 2659288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of worldwide clinical trials of aztreonam in patients with urinary tract infections.
    Swabb EA; Jenkins SA; Muir JG
    Rev Infect Dis; 1985; 7 Suppl 4():S772-7. PubMed ID: 3909336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter comparative study of aztreonam and gentamicin in the treatment of renal and urinary tract infections.
    Albertazzi A; Bonadio M; Fusaroli M; Lotti T; Miano L; Salvia G; Sasdelli M; Villa G; Zucchelli P; Ventriglia L
    Chemotherapy; 1989; 35 Suppl 1():77-80. PubMed ID: 2659293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of aztreonam in patients suffering from urinary tract infections with contraindications for the use of aminoglycosides.
    Fraschini F; Scaglione F; Alessandria M; Gattei G
    Chemioterapia; 1986 Oct; 5(5):319-21. PubMed ID: 3791478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria.
    Cox CE
    Rev Infect Dis; 1985; 7 Suppl 4():S767-71. PubMed ID: 3909335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined aztreonam and gentamicin therapy for pseudomonal lower respiratory tract infections.
    Andrews R; Fasoli R; Scoggins WG; Algozzine GJ; Spann RW; Sundaresh KV; Mathers JA; Babb R; Kuppinger M; Cooper B
    Clin Ther; 1994; 16(2):236-52. PubMed ID: 8062319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
    Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
    Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia.
    Fayed DF; Dahmash NS; Saddique AA; Shibl AM
    J Chemother; 1992 Jun; 4(3):167-70. PubMed ID: 1517810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An Italian multicenter study on the efficacy and tolerability of aztreonam in the treatment of urinary tract infections].
    Martelli A; Cortecchia V; Ventriglia L
    Clin Ter; 1988 May; 125(3):191-201. PubMed ID: 2973940
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with aztreonam in four Mediterranean countries.
    Daikos GK
    Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.
    Feris J; Moledina N; Rodriguez WJ; Khan WN; Puig J; Wiedermann BL; Ahmad S
    Chemotherapy; 1989; 35 Suppl 1():31-8. PubMed ID: 2731448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
    LeFrock JL; Smith BR; Chandrasekar P; Rolston KV; Molavi A; Kannangara W
    Arch Intern Med; 1987 Feb; 147(2):325-8. PubMed ID: 3813751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical efficacy of aztreonam in patients with complicated urinary tract infections].
    Yoshida K; Uchijima Y; Kobayashi N; Suwata J; Nakame Y; Saitoh H; Negishi T; Yamada T; Kageyama Y; Kura N
    Hinyokika Kiyo; 1988 Dec; 34(12):2225-32. PubMed ID: 3071130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical use of aztreonam.
    Schönwald S; Schoss-Vidensek Z; Car V; Krznar B
    Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aztreonam in the treatment of nosocomial urinary infections].
    Nardini A; Taddei P; Rossi F
    G Ital Chemioter; 1986; 33(2-3):139-42. PubMed ID: 3678719
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study of aztreonam in gram-negative pneumonia versus a therapeutic regimen that includes an aminoglycoside. Spanish Study Group.
    Marco V; Gobernado M; Santos M; Rabinad E
    Chemotherapy; 1989; 35 Suppl 1():81-8. PubMed ID: 2659295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on aztreonam, ceftazidime and amikacin in the treatment of complicated urinary tract infections.
    Melekos MD; Skoutelis A; Chryssanthopoulos C; Bassaris HP
    J Chemother; 1991 Dec; 3(6):376-82. PubMed ID: 1819621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.